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Background/aim: Exhaled CO level provides an objective measure of a patient’s smoking status. The relationship between CO levels
and nicotine dependence is controversial. The aim of this study is to evaluate the relationship between exhaled CO levels and nicotine
dependence as well as to demonstrate that exhaled CO levels may be used as a marker of nicotine dependence.
Materials and methods: Two hundred eighty-nine patients (132 females, 157 males) were included in the study. Smoking duration,
the age of smoking initiation, exhaled CO levels, and Fagerström Test for Nicotine Dependence (FTND) scores were recorded. The
relationship between FTND scores and exhaled CO levels was investigated.
Results: There was a statistically significant correlation between FTND score and exhaled CO levels (P < 0.001). We found that a cut-off
score of 7.5 ppm for exhaled CO may be useful as a marker for heavy smoking. The sensitivity and specificity of this cut-off score for
exhaled CO was 69.3% and 49.3%, respectively (P < 0.001).
Conclusion: We found that exhaled CO levels significantly correlated with FTND scores. For patients who are unable to provide reliable
answers to questions in the FTND, exhaled CO measurements may be used as an alternative test for estimating the status of heavy
smoking.
Key words: Carbon monoxide, Fagerström test, nicotine dependence

1. Introduction
Smoking is an important global public health concern.
It has been classified as a disorder according to the
International Classification of Diseases (10th Revision,
F.17) and is a dispensable habit according to World Health
Organization (1).
The severity of nicotine dependence is important in the
evaluation of patient smoking habits in tobacco control
programs (1,2). Certain scales for measuring the severity
of dependence include the Fagerström Test for Nicotine
Dependence (FTND) (3), the Cigarette Dependence Scale
(4), and the Nicotine Dependence Syndrome Scale (5).
Among these, the FTND scale is most commonly used. It
consists of a questionnaire related to the smoking habits
of patients in six domains. Although this scale is easy to
apply and is noninvasive, the duration of time required to
answer all questions is too long to be reliably completed in
most clinical settings. Additionally, some patients do not
give honest answers to the questions, which is a problem.
Another method that has been used for assessing the
severity of smoking dependence is simply counting the
* Correspondence: elifbabaoglu@hotmail.com

number of cigarettes smoked within 24 h (cigarettes per
day, CPD) (6). This is a quantitative measure that has been
used in many population-based studies.
Measurement of exhaled carbon monoxide (CO) levels
is commonly performed in smoking cessation programs
for the purpose of increasing the motivation of patients.
This test obtains information on patient smoking status.
CO level in expired air has been used as an indicator of
smoking in several studies (7–10). Controversial results
persist regarding whether CO measurement can be used
as a marker for demonstrating the severity of nicotine
dependence. Therefore, we aimed to investigate the
relationship between exhaled CO levels and the severity of
nicotine dependence.
2. Materials and methods
Two hundred eighty-nine patients (132 females, 157 males)
who referred to the Smoking Cessation Unit of Ankara
Atatürk Training and Research Hospital were included
in the study. The study was approved by the Local Ethics
Committee of Ankara Atatürk Training and Research
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We examined whether FTND scores were correlated
with CPD numbers and exhaled CO levels. It was observed
that FTND scores correlated well with both CPD numbers
(r = 0.668; P < 0.01) and exhaled CO levels (r = 0.233; P <
0.001; Figure 1).
The patients were classified into five groups according
to their FTND scores: 1) very low, 2) low, 3) moderate, 4)
high, and 5) very high nicotine dependence, as shown in
Table 3. Mean exhaled CO levels were similar in females
and males within each group (Table 3).
We compared exhaled CO levels of all patients with
their FTND scores using ROC analysis to investigate if
a cut-off level for heavy smoking could be determined
(Figure 2). ROC analysis yielded that the cut-off score for
exhaled CO levels was 7.5 ppm. This value was comparable
with the cut-off value of 6 for the FTND. The sensitivity
calculated for ROC analysis was 69.3% and the specificity
was 49.3% (P < 0.001).

Hospital (2011.05.46). The FTND scale was applied to all
patients, and exhaled CO levels were measured. For all
patients, smoking duration, the age of smoking initiation,
exhaled CO levels, and FTND scores were recorded. The
relationship between FTND scores and exhaled CO levels
was investigated.
2.1. Statistical analysis
Statistical analyses of the study were performed using
SPSS 15.0 (SPSS Inc., Chicago, IL, USA). Means ±
standard deviations for metric variables and frequencies as
percentages for categorical variables were used. Student’s
t-test or the Mann–Whitney U test was used to compare
two independent groups for metric variables. Spearman’s
correlation coefficient was used to assess the relationships
between two variables. A value of P < 0.05 was considered
statistically significant. To determine the cut-off score
for CO measurements, receiver operating characteristics
(ROC) analysis was performed. The area under the ROC
curve measures the potential of the ordinal scale for
detecting high nicotine dependence with accuracy.

4. Discussion
In this study, we found that there are some differences
between females and males regarding smoking habits
and nicotine dependence. As indicated by FTND scores,
nicotine dependence of females was higher than that of
males, although males started to smoke earlier and had
longer smoking duration than females. However, CO
levels of females and males were similar in each group of
patients. When patients were subgrouped according to
smoking levels, CO levels and FTND scores were positively
correlated in both females and males.
The FTND is the most commonly used test for the
evaluation of nicotine dependence. It takes a long time
to ask all of the questions. Some alternative tests are also
being investigated. In the study by Charbol et al. (11),
the cut-off score for the Heavy Smoking Index (HSI) was
found to be useful for the diagnosis of heavy smoking. The

3. Results
Demographic features of the 289 patients are summarized
in Table 1. According to the variables in Table 1, the mean
age of the females (40.1 ± 9.6 years) was similar to that of the
males (42.8 ± 13.2 years) (P = 0.05). The average smoking
duration of the males was significantly longer than that of
the females (25.2 ± 13 vs. 20.7 ± 9 years, respectively; P =
0.001). In addition, the mean age of smoking initiation was
earlier in males than in females (17.3 ± 5.1 vs. 19.2 ± 5.4
years, respectively; P = 0.002).
Mean FTND scores and exhaled CO levels are
presented in Table 2. FTND scores were significantly
higher in females than in males (P = 0.009). Exhaled CO
levels in both sexes were similar at approximately 11 parts
per million (ppm).
Table 1. Demographic features of the patients.
Females (n = 132)

Males (n = 157)

P-value

Age (years)

40.1 ± 9.6

42.8 ± 13.2

0.05

Smoking duration (years )

20.7 ± 9

25.2 ± 13

0.001

Age of starting smoking (years)

19.2 ± 5.4

17.3 ± 5.1

0.002

Table 2. Mean exhaled CO levels and FTND scores of the patients.
Females (n = 132)

Males (n = 157)

P-value

FTND score

6.0 ± 2.6

5.2 ± 2.2

0.009

Exhaled CO level (ppm)

11.5 ± 8.3

11.0 ± 7.4

0.570
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Figure 1. Correlation between FTND score and exhaled CO levels (r: 0.233, P < 0.001).
Table 3. CO levels and the FTND scores of the patients.
Nicotine dependence
(FTND score)
Very low
(0–2)

Low
(3–4)

Moderate
(5–6)

High
(6–7)

Very high
(8–10)

n

CO levels (mean ± SD)

Females

11

11.1 ± 6.8

Males

23

7.3 ± 4.5

Total

34

8.5 ± 5.5

Females

29

9.3 ± 9.6

Males

40

8.5 ± 6.2

Total

69

8.8 ± 7.8

Females

14

11.2 ± 8.0

Males

19

13.1 ± 7.4

Total

33

12.3 ± 7.6

Females

40

10.1 ± 6.0

Males

49

12.1 ± 8.8

Total

89

11.2 ± 7.7

Females

37

14.4 ± 8.9

Males

26

14.2 ± 6.4

Total

63

14.4 ± 7.9

P

0.12

0.86

0.439

0.425

0.78
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Figure 2. The ROC curve for CO cut-off score.

cut-off score for the HSI was 4 with a sensitivity of 80%
and a specificity of 97% (10). Lim et al. found that CPD
was not a suitable alternative to the FTND (12).
Exhaled CO level has been used as a biological
indicator to assess the smoking status of patients (13). It
can also be used to show the impact of active smoking
and environmental tobacco smoke exposure on nicotine
dependence (14,15). Furthermore, it was demonstrated
that exhaled CO levels could discriminate between smokers
and nonsmokers, yielding an optimal discrimination at
a cut-off level of 5.5 ppm with a sensitivity of 95% and a
specificity of 83% (8). In addition, exhaled CO was found
to be a biomarker that captures aspects of cigarette smoke
exposure beyond the CPD number in current smokers
(16). Studies on the relationship between exhaled CO and
the severity of nicotine dependence yielded controversial
results. Kapusta et al. showed that CO levels did not
discriminate based on the severity of nicotine dependence
(8). On the other hand, Vancelik et al. showed that exhaled
CO could be used as an indicator of nicotine dependence
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in adolescents (17). In the present study, exhaled CO levels
positively correlated with FTND scores. In ROC analysis,
we found that a cut-off score of 7.5 ppm may be used to
predict heavy smoking habits. Exhaled CO levels of >7.5
ppm may be useful to discriminate heavy smokers from
others. The sensitivity and specificity of this cut-off score
for exhaled CO measurements were 69.3% and 49.3%,
respectively. Although the sensitivity and specificity of
CO measurements are smaller than those of the HSI for
patients who do not provide honest answers to the FTND
and HSI or for busy clinicians, CO measurements may be
useful to diagnose heavy smoking habits.
As a result, our findings suggest that the measurement
of exhaled CO levels is indicative of the severity of
smoking. Additionally, CO levels of >7.5 ppm may be
useful to determine heavy smoking habits, especially in
clinical settings in which the FTND questionnaire cannot
be applied because of time limitations of both patients and
physicians.
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